SCHEMBL4927472

SCHEMBL4927472

CCCNc1cc(Cl)cc(COc2c(Br)cc(C(=O)NCC(=O)O)cc2Br)c1F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.36
MAPT P10636 2/20 0.36
RAB9A P51151 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
LMNA P02545 3/20 0.34
GPR139 Q6DWJ6 2/20 0.34
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
FABP4 P15090 1/20 0.33
ACLY P53396 1/20 0.32
THRA P10827 4/20 0.32
THRB P10828 4/20 0.32
HPGD P15428 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
HDAC3 O15379 1/20 0.32
MMP1 P03956 1/20 0.32
DDR1 Q08345 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4922926 0.92 SMN1; SMN2 (0.38) SMN1; SMN2MAPTRAB9AL3MBTL1LMNA
SCHEMBL4930661 0.91 KMT2A (0.38) SMN1; SMN2MAPTRAB9ALMNAGPR139
SCHEMBL4934028 0.90 SMN1; SMN2 (0.36) SMN1; SMN2MAPTRAB9AL3MBTL1LMNA
SCHEMBL4922427 0.88 SMN1; SMN2 (0.36) SMN1; SMN2MAPTRAB9AL3MBTL1LMNA
SCHEMBL4934502 0.87 GPR139 (0.37) SMN1; SMN2MAPTRAB9AL3MBTL1LMNA
SCHEMBL5113399 0.86 ACLY (0.37) SMN1; SMN2MAPTRAB9AL3MBTL1LMNA
SCHEMBL4934628 0.86 SMN1; SMN2 (0.40) SMN1; SMN2MAPTRAB9AL3MBTL1LMNA
SCHEMBL5104287 0.86 THRA (0.37) SMN1; SMN2MAPTRAB9AL3MBTL1LMNA
SCHEMBL5718277 0.86 ALDH1A1 (0.35) SMN1; SMN2MAPTRAB9ALMNAALDH1A1
SCHEMBL5104790 0.86 BRD4 (0.36) SMN1; SMN2MAPTRAB9AL3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA SMN1; SMN2 4282/4885MAPT 4142/4885RAB9A 986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.